Hepatitis C virus infection and haemodialysis: Experience of a district general hospital in Brunei Darussalam

Singapore Medical Journal

Volumn 49, Issue 11, 2008, Pages 916-920

  Chong, Vui Heng ^a   Zinna, H S ^b  

^a RIPAS HOSPITAL   (Brunei Darussalam)

^b Department of Renal Medicine ^*

Author keywords

End stage renal failure; Genotypes; Haemodialysis; Hepatitis C

Indexed keywords

IMMUNOGLOBULIN G; INTERFERON; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BRUNEI DARUSSALAM; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; GENERAL HOSPITAL; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; TREATMENT DURATION; TREATMENT OUTCOME;

BRUNEI; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HOSPITALS, DISTRICT; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; MALE; PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RNA, VIRAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 57149112762     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Tong MJ, el-Farra MS, Reikes AR, Co RL. Clinical outcomes after transfusion associated hepatitis C. N Eng J Med 1995; 332:1463-6.
2. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and patients with end-stage renal disease. Hepatology 2002; 36:3-10.
3. Salama G, Rostaing L, Sandres K, Izopet J. Hepatitis C infection in French hemodialysis unit; a multicenter study. J Med Virol 2000: 61:44-51.
4. Jaiswal SP, Chitnis DS, Naik G, et al. Prevalence of anti-HCV antibodies in central India. Indian J Med Res. 1996; 104:177-81.
5. Tokars JI, Frank M, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 2002; 15:162-71.
6. Martin P, Carter D, Fabrizi F, et al. Histopathological features of hepatitis C in renal transplant candidates. Transplantation 2000; 69:1479-84.
7. Caramelo C, Ortiz A, Aguilera B, et al. Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis 1993; 22:822-8.
8. Chong VH, Jamaludin AZF, Jacob AP, Alexander M, Jalihal A. Characteristics of Hepatitis C in Negara Brunei Darussalam. Liver Inter 2005; 25:A110.
9. Jadoul M, Cornu C, Van Ypersele de Strihou C. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group. Kidney Int 1993; 44:1322-6.
10. Garcia-Valdecasas J, Bernal C, Garcia F, Leyva A, Cerezo S. Epidemiological factors involved in hepatitis C virus infection in hemodialysed patients. Nephrol Dial Transplant 1995; 10:81-2.
11. Okuda K, Hayashi H, Kobayashi S, Irie Y. Mode of Hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol 1995; 23:28-31.
12. Donahue JG, Munoz A, Ness PM, et al. The declining risk of post-tranfusion hepatitis C virus infection. N Engl J Med 1992; 327:369-73.
13. Furusyo N, Kubo N, Nakashima H, et al. Confirmation of nosocomial hepatitis C virus infection in a hemodialysis unit. Infect Control Hosp Epidemiol 2004: 25:584-90.
14. Forns X, Fernandez-Llama, Pons M, et al. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit. Nephrol Dial Transplant 1997; 12:736-40.
15. Chong VH, Jamaludin AZ, Jalihal A. Hepatitis C in Brunei Darussalam: a genotypic study. J Gastroenterol Hepatol 2006: 21(Suppl 1):A19.
16. Morales J, Munoz MA, Castellano G, et al. Impact of hepatitis C in long-functioning renal transplants: a clinico-pathological follow-up. Transplant Proc 1993; 25:1450-3.
17. Neumann U, Puhl G, Bahra M, et al. Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin. Transplantation 2006; 82:43-7.
18. Chauveau P, Courouce AM, Lemarrec N, et al. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients. Kidney Int 1993; 43(Suppl 41):S149-52.
19. Qunibi WY. Reducing the burden of cardiovascular calcification in patients with chronic kidney disease. J Am Soc Nephrol 2005; 16 Suppl 2:S95-102.
20. Koren-Morag N, Goldbourt U, Tanne D. Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology 2006; 67:224-8.
21. Saeed Abdulrahman I, Al-Mueilo SH, Bokhary HA, Ladipo GO, Al-Rubaish A. A prospective study of hemodialysis access-related bacterial infections. J Infect Chemother 2002; 8:242-6.